NRP1 and central nervous system cancer: Indeed, Miyauchi et al. (2016, 2018) demonstrated that the deletion of NRP1 in microglia leads to the reduction of glioma progression in vivo and its expression in microglial cells is correlated with poor prognosis in high grade gliomas (Caponegro et al., 2018).